Article ID Journal Published Year Pages File Type
5884685 Journal of Clinical Anesthesia 2016 10 Pages PDF
Abstract
Although a longer duration follow-up study in a larger patient population would expand our understanding of potential CV risks, the present analysis suggests that postoperative use of HPβCD-diclofenac does not present an added CV safety risk over placebo.
Related Topics
Health Sciences Medicine and Dentistry Anesthesiology and Pain Medicine
Authors
, , , , , , ,